Filing Details

Accession Number:
0001415889-25-008107
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-03-14 16:30:19
Reporting Period:
2025-03-12
Filing Date:
2025-03-14
Accepted Time:
2025-03-14 16:30:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1808158 Repare Therapeutics Inc. RPTX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1815366 Michael Zinda C/O Repare Therapeutics Inc.
St-Laurent A8 H4S 1Z9
Evp, Chief Scientific Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Disposition 2025-03-12 5,611 $1.14 80,297 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Represent shares sold to satisfy the Reporting Person's tax withholding obligation in connection with the vesting and settlement of restricted stock units and does not represent a discretionary sale by the holder.